Using patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public"
- PMID: 21911630
- PMCID: PMC3940388
- DOI: 10.1001/archinternmed.2011.369
Using patients to promote evidence-based prescribing: comment on "Communicating uncertainties about prescription drugs to the public"
Comment on
-
Communicating uncertainties about prescription drugs to the public: a national randomized trial.Arch Intern Med. 2011 Sep 12;171(16):1463-8. doi: 10.1001/archinternmed.2011.396. Arch Intern Med. 2011. PMID: 21911629 Clinical Trial.
References
-
- Merck Announces Fourth Quarter and Full Year 2010 Financial Results (Press release) 2011 Jun 13; http://www.merck.com/newsroom/news-release-archive/financial/2011_0203.html. Accessed.
-
- Schwartz LM, Woloshin S. Communicating uncertainties about prescription drugs to the public: a national randomized trial. Arch Intern Med. 2011 [NEED TO UPDATE REFERENCE] - PubMed
-
- Schiff GD, Galanter WL. Promoting more conservative prescribing. JAMA. 2009;301(8):865–867. - PubMed
-
- Chen DT, Wynia MK, Moloney RM, Alexander GC. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Pharmacoepidemiol Drug Saf. 2009;18(11):1094–1100. - PubMed
-
- Bero LA, Grilli R, Grimshaw JM, Harvey E, Oxman AD, Thomson MA. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. The Cochrane Effective Practice and Organization of Care Review Group. Bmj. 1998;317(7156):465–468. - PMC - PubMed